This Article Abstract Full Text (PDF) All Versions of this Article: 35/8/1963    most recent 01.STR.0000132764.06878.c5v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Didion, S. P. Articles by Faraci, F. M. Search for Related Content PubMed PubMed Citation Articles by Didion, S. P. Articles by Faraci, F. M. Related Collections Oxidant stress Endothelium/vascular type/nitric oxide Genetically altered mice

(Stroke. 2004;35:1963.)
© 2004 American Heart Association, Inc.

Original Contributions

Overexpression of CuZn-SOD Prevents Lipopolysaccharide-Induced Endothelial Dysfunction

Sean P. Didion, PhD; Dale A. Kinzenbaw, BS; Pamela E. Fegan, BS; Lisa A. Didion, BS Frank M. Faraci, PhD

From the Departments of Internal Medicine and Pharmacology, Cardiovascular Center, University of Iowa, Carver College of Medicine, Iowa City, Iowa.

Correspondence to Dr Frank M. Faraci, Department of Internal Medicine, E318-2-GH, University of Iowa, Carver College of Medicine, Iowa City, IA 52242-1081. E-mail frank-faraci{at}uiowa.edu

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background and Purpose— Inflammation is thought to be a major contributor to carotid artery disease. Lipopolysaccharide (LPS) activates inflammatory mechanisms thought to contribute to endothelial dysfunction by mechanisms that are not well defined. The goal of this study was to determine whether overexpression of CuZn-SOD protects against LPS-induced increases in superoxide and endothelial dysfunction.

Methods— Carotid arteries from CuZn-SOD transgenic (SOD-Tg) and nontransgenic (non-Tg) littermates were examined in vitro. Superoxide levels were measured using lucigenin-enhanced chemiluminescence.

Results— In non-Tg mice, LPS (0.5 µg/mL for 22 hours) produced marked impairment of vasorelaxation in response to the endothelium-dependent dilator acetylcholine (ACh). For example, 100 µmol/L ACh relaxed carotid arteries from non-Tg mice by 86±6% and 38±8% after treatment with vehicle and LPS, respectively. In contrast, LPS did not significantly impair responses of carotid artery to ACh in SOD-Tg mice, and LPS had no effect on relaxation responses to the endothelium-independent dilator nitroprusside in carotid artery from non-Tg or SOD-Tg mice. LPS-induced increases in superoxide, as measured using lucigenin-enhanced chemiluminescence, were higher in vessels from non-Tg mice than from SOD-Tg mice.

Conclusions— These results indicate that LPS increases superoxide and impairs endothelium-dependent relaxation. Overexpression of the CuZn isoform of SOD effectively prevents LPS-induced oxidative stress and endothelial dysfunction in the carotid artery.

Key Words: animal models • carotid arteries • endothelium • inflammation • reactive oxygen species • superoxide dismutase

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Impairment of endothelial function is seen in experimental models of inflammation, including exposure to lipopolysaccharide (LPS) and proinflammatory cytokines.^1–9 Vascular inflammation is also present, or components of the inflammatory response are activated, within the vessel wall in many cardiovascular diseases, including carotid artery disease.^10–15

The mechanisms that account for endothelial dysfunction during vascular inflammation are not clear. Previous studies in this area either have not addressed mechanisms that produce endothelial dysfunction or have provided divergent results and implicated a variety of mechanisms in relation to impairment of endothelium-dependent relaxation. For example, although increases in reactive oxygen species (ROS) including superoxide anion, have been suggested to contribute to endothelial dysfunction, pharmacological scavengers of superoxide and other antioxidants have had inconsistent effects in models using LPS.^1,3,7,16,17 In 1 case, scavenging of superoxide actually worsened LPS-induced endothelial dysfunction.¹ Thus, the role of superoxide as a mediator of endothelial dysfunction during inflammation is unclear.

LPS is known to activate nicotinamide adenine dinucleotide (phosphate) (NAD[P]H) oxidase and other mechanisms that increase intracellular superoxide.^1,18–20 Increased vascular superoxide can exert a variety of effects, including inactivation of nitric oxide and formation of peroxynitrite. Peroxynitrite can cause nitration of protein tyrosine residues, and this effect occurs predominantly intracellularly in vascular cells in response to inflammatory stimuli.²¹ Based on such findings, we hypothesized that overexpression of the isoform of superoxide dismutase (SOD), which is primarily cytosolic (CuZn-SOD, SOD-1), would be effective in protecting against LPS-induced endothelial dysfunction. Thus, the goal of this study was to use a genetic approach to determine if overexpression of CuZn-SOD protects against LPS-induced increases in superoxide and endothelial dysfunction. LPS is commonly used to activate inflammatory mechanisms in blood vessels, including activation of nuclear factor B and production of proinflammatory cytokines. We studied carotid arteries, as inflammatory mechanisms are thought to be a major contributor to carotid artery disease, a risk factor for stroke.²² Using CuZn-SOD transgenic (SOD-Tg) and nontransgenic (non-Tg) littermates, we found that LPS increases superoxide and impairs endothelium-dependent relaxation, and that these effects are prevented by overexpression of CuZn-SOD.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Animal Preparation
The animal protocol used in these experiments was reviewed and approved by the University of Iowa Animal Care and Use Committee. Mice for this study were derived from breeding of male hemizygous CuZn-SOD (human)-transgenic [C57BL/6-TgN(SOD-1)10je] mice with female C57BL/6J mice to generate SOD-Tg and non-Tg mice within the same litter (Jackson Labs, Bar Harbor, Maine). This approach allowed us to use non-Tg littermates as controls. Mice were fed regular chow and water, which were available ad libitum. The ages of mice in the different groups were similar (non-Tg, 10±1 month; SOD-Tg, 11±1 month), and both male and female mice were studied. Genotyping of mice was performed using PCR of DNA from tail biopsies.

General Preparation
The method used to measure responses of carotid arteries in mice has been described in detail.^3,12,23,24 Briefly, mice were anesthetized with pentobarbital (100 mg/kg, intraperitoneally) followed by removal of both carotid arteries and the thoracic aorta. Arteries were placed in Krebs buffer, loose connective tissue was removed, and vessels were cut into rings (3 to 4 mm in length). Each segment of carotid artery and aorta was placed in individual wells using 48-well cell culture dishes containing 0.5 mL DMEM containing 5 mmol/L glucose, 120 U/mL penicillin, 120 µg/mL streptomycin, and 50 µg/mL polymyxin B. Vessels were then incubated with either vehicle (ddH₂O) or LPS (0.5 µg/mL Escherichia coli, serotype 026:B6; Sigma-Aldrich, St. Louis, Missouri) for 22 hours at 37°C.

Following incubation, vascular rings were connected to a force transducer to measure isometric tension in an organ bath containing Krebs solution maintained at 37°C. Resting tension was increased stepwise to reach a final tension of 0.25 g, and the rings were allowed to equilibrate for at least 45 minutes. This amount of resting tension is optimal for contraction of murine carotid arteries.

Protocol
Relaxation of carotid arteries in response to acetylcholine (Sigma) and nitroprusside (Sigma) was measured following submaximal precontraction using the thromboxane analog, U46619 (9,11-dideoxy-11a,9a-epoxy-methanoprostaglandin F₂; Biomol Research Laboratories Inc). Using pharmacological approaches and gene-targeted mice, we and others have shown previously that responses of the carotid artery to acetylcholine are mediated by endothelial nitric oxide synthase (eNOS).²³ At the end of each experiment, we obtained full dose responses of each carotid artery to U46619 (0.03 to 3 µg/mL) to determine maximal contractile responses.

Measurement of SOD Protein and Activity
Total SOD activity of aortic homogenates from non-Tg and SOD-Tg mice was determined as described.²⁴ CuZn-SOD protein expression in the aorta of both groups of mice was examined by Western blotting as described.²⁴

Measurement of Superoxide
Superoxide levels were measured using aorta and 5 µmol/L lucigenin-enhanced (Sigma) chemiluminescence as described in detail.^24,25 Basal (control) levels of superoxide are reported as the value of tissue plus lucigenin-containing buffer minus background. Superoxide levels were normalized per dry weight. We have shown previously that the signal obtained using this approach is markedly inhibited by scavengers of superoxide (PEG-SOD or Tiron).^24,25

Drugs
U46619 was obtained from Biomol Research Laboratories Inc and dissolved in 100% ethanol. Acetylcholine, nitroprusside, and LPS (#L-8274, E. coli, serotype 026:B6) were obtained from Sigma Chemical Co and dissolved in distilled water. Lucigenin was obtained from Sigma Chemical Co and dissolved in PBS.

Statistical Analysis
Contractions are presented as grams of tension developed and are presented as mean±SEM. Relaxation in response to acetylcholine and nitroprusside are presented as % change in tension from the level of precontraction. When multiple vessel rings were studied from 1 mouse, responses were averaged and n represents the number of mice per group. Comparisons were made using a 1-way ANOVA with repeated measures followed by the Student–Newman–Keuls test to detect individual differences. A P<0.05 was defined as significant.

	Results

Top Abstract Introduction Methods Results Discussion References

 
SOD Activity and CuZn-SOD Protein Expression
Western blotting confirmed that CuZn-SOD protein was present in higher levels in vascular tissue in SOD-Tg mice (Figure 1). Two distinct bands were observed in aorta from SOD-Tg mice. The lower band corresponds to endogenous mouse CuZn-SOD, and the slightly higher band corresponds to human CuZn-SOD (human CuZn-SOD is known to be slightly larger than mouse CuZn-SOD).²⁶ As expected, total SOD activity was higher in aorta from SOD-Tg mice compared with non-Tg mice (Figure 1).

View larger version (12K): [in this window] [in a new window]   Figure 1. Western blot for CuZn-SOD protein expression in aorta from non-Tg and SOD-Tg mice (left). This Western blot is representative of 4 separate experiments. Total SOD activity (U/mg) (right) expressed as U/mg total protein in aortic homogenates from non-Tg (n=5) and SOD-Tg mice (n=5). Values are mean±SE. *P<0.05 vs non-Tg.

Increases in Vascular Superoxide in Response to LPS Are Prevented in SOD-Tg Mice
Superoxide levels, as measured using lucigenin-enhanced chemiluminescence, were higher in vessels treated with LPS than in those treated with vehicle in non-Tg control mice (Figure 2). In contrast, increases in superoxide in response to LPS were greatly reduced in SOD-Tg mice (Figure 2). These findings indicate that overexpression of CuZn-SOD is effective in preventing large LPS-mediated increases in vascular superoxide.

View larger version (17K): [in this window] [in a new window]   Figure 2. Superoxide levels (as detected by lucigenin-enhanced chemiluminescence) in aorta from non-Tg (n=13) and SOD-Tg mice (n=6) after treatment with vehicle (control) or LPS. Values are mean±SE. *P<0.05 vs control; P<0.05 vs SOD-Tg with LPS.

Vascular Responses in Non-Tg and SOD-Tg Mice
U46619 produced concentration-dependent contraction of carotid arteries. For relaxation studies, arteries were contracted to 60% to 70% of maximum using 0.3 µg/mL U46619. The response to this concentration of U46619 was similar in non-Tg and SOD-Tg mice and was not affected by LPS (P>0.05). Carotid arteries contracted by 0.23±0.02 and 0.20±0.02 g in non-Tg mice treated with vehicle and LPS, respectively. In SOD-Tg mice, carotid arteries contracted by 0.18±0.03 and 0.17±0.04 g following treatment with vehicle and LPS, respectively. Thus, at the concentration used in these studies, vasoconstriction to U46616 was not affected by LPS.

Responses of the carotid artery to acetylcholine under normal conditions were similar in non-Tg mice and SOD-Tg mice (Figure 3). Thus, overexpression of CuZn-SOD per se does not alter endothelial function. In arteries from non-Tg mice, acetylcholine-induced relaxation was markedly inhibited by LPS (Figure 3). For example, in non-Tg mice, relaxation in response to 100 µmol/L acetylcholine was 86±6% and 38±8% in carotid arteries treated with vehicle and LPS, respectively (Figure 3). In contrast to arteries from non-Tg mice, LPS did not significantly affect responses to acetylcholine in vessels from SOD-Tg mice (Figure 4).

View larger version (19K): [in this window] [in a new window]   Figure 3. Relaxation of carotid arteries from non-Tg mice (n=10, left) and SOD-Tg mice (n=7, right) in response to acetylcholine following treatment with vehicle (control) or LPS. Values are mean±SE. *P<0.05 vs control.

View larger version (16K): [in this window] [in a new window]   Figure 4. Relaxation of carotid arteries from non-Tg mice (n=10, left) and SOD-Tg mice (n=7, right) in response to nitroprusside following treatment with vehicle or LPS. Values are mean±SE.

In arteries from non-Tg and SOD-Tg mice, nitroprusside produced similar relaxation in vessels treated with vehicle or LPS (Figure 4). Thus, LPS did not inhibit vasorelaxation in response to nitroprusside in either non-Tg or SOD-Tg animals. These findings indicate that impaired responses to acetylcholine following LPS in non-Tg mice were selective for the endothelium-dependent agonist and were not a result of generalized nonspecific alteration in vascular function.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
There are several major findings in this study. First, superoxide levels were increased in vessels from non-Tg control mice following local treatment with LPS. Second, LPS produced marked impairment of vasorelaxation in response to acetylcholine in non-Tg mice. This effect was selective as vascular responses to nitroprusside were not affected by LPS. Third, in contrast to non-Tg animals, increases in vascular superoxide were greatly attenuated and responses to acetylcholine were essentially normal in carotid arteries from SOD-Tg mice following treatment with LPS. These results indicate that LPS increases superoxide and impairs endothelium-dependent relaxation. Overexpression of the CuZn isoform of SOD effectively prevents LPS-induced oxidative stress and endothelial dysfunction.

Vascular inflammation is present, or components of the inflammatory response are activated, within blood vessels with aging¹⁴ and in many cardiovascular diseases including atherosclerosis (carotid artery disease), diabetes, hypertension, and hyperhomocysteinemia.^10–13,15 This vascular inflammation is thought to contribute significantly to vascular dysfunction, including endothelial dysfunction, in these disease states.

Many studies have used LPS to activate inflammatory mechanisms, including nuclear factor B and production of proinflammatory cytokines, in blood vessels. In this experimental model, impairment of endothelium-dependent relaxation is commonly observed.^1–9,17,27 Nitric oxide, which is the major mediator of endothelium-dependent relaxation, reacts with superoxide at a rate 3 times faster than dismutation of superoxide by SOD. LPS and proinflammatory cytokines increase levels of superoxide and peroxynitrite within intact blood vessels and in vascular cells in culture,^{1,3,16,21,28,29} but the functional importance of these changes has been very difficult to define. For example, treatment with exogenous scavengers of superoxide have had no effect or have worsened endothelial dysfunction in these models.^1,4 In contrast, high concentrations of vitamin C improved impaired vascular responses to acetylcholine following LPS.⁷ An explanation for these divergent results is not clear. There are potential limitations with the use of pharmacological scavengers or exogenous SOD, including cytotoxicity and uncertainties in subcellular access and the degree of scavenging of superoxide. In addition, scavengers of superoxide may have nonspecific effects.³⁰ Even when an antioxidant has positive effects, as in the case of vitamin C in 1 study,⁷ the use of this strictly pharmacological approach provides no insight into subcellular localization of oxidative stress and site of action of superoxide.

The protection by overexpression of CuZn-SOD observed in this study suggests that increases in superoxide in intracellular or cytosolic compartments following LPS are functionally important. This conclusion is consistent with recent work, which suggests that superoxide contributes to intracellular protein tyrosine nitration (via its reaction with nitric oxide and production of peroxynitrite) in vascular muscle during inflammation.²¹ Potential sources of superoxide in inflammation, such as NAD(P)H oxidase, are known to increase superoxide intracellularly.^18–20 Because superoxide is charged and may not easily diffuse across cell membranes, we hypothesized that overexpression of the isoform of SOD that is expressed in close proximity to these intracellular increases in superoxide would be protective in inflammation. Our results are consistent with this hypothesis in that overexpression of CuZn-SOD was very effective in protecting against LPS-induced increases in superoxide and endothelial dysfunction.

In addition to CuZn-SOD, 2 other isoforms of SOD are expressed within the vessel wall: mitochondrial or Mn-SOD (SOD-2), and extracellular or EC-SOD (SOD-3). Within blood vessels, the predominant isoform of SOD is CuZn-SOD, accounting for approximately 50% to 80% of total SOD activity.^24,31,32 Constitutive levels of these SODs were not sufficient to prevent increases in superoxide and endothelial dysfunction in response to a high concentration of LPS in vessels from non-Tg (normal) animals (ie, LPS increased superoxide and produced endothelial dysfunction in this and in previous studies). In SOD-Tg mice, levels of CuZn-SOD protein and SOD activity are increased several-fold (present study).³³ This level of overexpression of CuZn-SOD was sufficient to prevent LPS-induced vascular dysfunction.

It is worth noting that overexpression of any SOD will not always be beneficial or protective, because higher levels of hydrogen peroxide result from increased expression of SOD and hydrogen peroxide can have deleterious effects in some systems. Thus, although it was possible that vascular dysfunction would not be improved by overexpression of CuZn-SOD, we did not find this to be the case. Endothelial function was not altered by overexpression of CuZn-SOD per se (in the absence of LPS) and endothelium was protected from LPS-induced dysfunction.

In summary, overexpression of CuZn-SOD protects against LPS-induced increases in superoxide and vascular dysfunction. These results complement previous work demonstrating that overexpression of this isoform of SOD attenuates/protects against vasospasm after subarachnoid hemorrhage³⁴ as well as endothelial dysfunction produced by ceramide³⁵ and overexpression of amyloid precursor protein.³⁶ SOD-Tg mice are also protected from increases in vascular superoxide, peroxynitrite, and blood pressure in response to angiotensin II.³⁷ Overall, these studies suggest that overexpression of CuZn-SOD is very effective in attenuating oxidative stress and in attenuating vascular dysfunction in several disease models.

	Acknowledgments

 
This work was supported by National Institutes of Health grants HL-38901, HL-62984, and NS-24621. Dr Sean Didion was funded by DK-25295 and a National Scientist Development Grant from the American Heart Association (0230327N). Genotyping was performed by Norma Sinclair in the University of Iowa Transgenic Facility under the direction of Dr Curt Sigmund. We thank Dr Larry Oberley for providing the CuZn-SOD antibody.

Received January 30, 2004; revision received April 7, 2004; accepted April 22, 2004.

	References

Top Abstract Introduction Methods Results Discussion References

 

1. Brandes RP, Koddenberg G, Gwinner W, Kim D, Kruse HJ, Busse R, Mugge A. Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia. Hypertension. 1999; 33: 1243–1249.[Abstract/Free Full Text]
2. Gocan NC, Scott JA, Tyml K. Nitric oxide produced via neuronal NOS may impair vasodilatation in septic rat skeletal muscle. Am J Physiol. 2000; 278: H1480–H1489.
3. Gunnett CA, Heistad DD, Berg DJ, Faraci FM. IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am J Physiol. 2000; 279: H1555–H1562.
4. Kessler P, Bauersachs J, Busse R, Schini-Kerth VB. Inhibition of inducible nitric oxide synthase restores endothelium-dependent relaxations in proinflammatory mediator-induced blood vessels. Arterioscler Thromb Vasc Biol. 1997; 17: 1746–1755.[Abstract/Free Full Text]
5. Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, Donald AE, Palacios M, Griffin GE, Deanfield JE, MacAllister RJ, Vallance P. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000; 102: 994–999.[Abstract/Free Full Text]
6. Pleiner J, Heere-Ress E, Langenberger H, Sieder AE, Bayerle-Eder M, Mittermayer F, Fuchsjager-Mayrl G, Bohm J, Jansen B, Wolzt M. Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol. 2002; 22: 95–100.[Abstract/Free Full Text]
7. Pleiner J, Mittermayer F, Schaller G, MacAllister RJ, Wolzt M. High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation. 2002; 106: 1460–1464.[Abstract/Free Full Text]
8. Parker JL, Adams HR. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res. 1993; 72: 539–551.[Abstract/Free Full Text]
9. Chauhan SD, Seggara G, Vo PA, MacAllister RJ, Hobbs AJ, Ahluwalia A. Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J. 2003; 17: 773–775.[Abstract/Free Full Text]
10. Faraci FM. Hyperhomocysteinemia: a million ways to lose control. Arterioscler Thromb Vasc Biol. 2003; 23: 371–373.[Free Full Text]
11. Virdis A, Schiffrin EL. Vascular inflammation: a role in vascular disease in hypertension? Curr Opin Nephrol Hypertens. 2003; 12: 181–187.[CrossRef][Medline] [Order article via Infotrieve]
12. Gunnett CA, Heistad DD, Faraci FM. Interleukin-10 protects endothelium-dependent relaxation during diabetes: role of superoxide. Diabetes. 2002; 51: 1931–1937.[Abstract/Free Full Text]
13. Aljada A. Endothelium, inflammation, and diabetes. Metabolic Syndrome and Related Disorders. 2003; 1: 3–21.
14. Cascieri MA. The potential for novel anti-inflammatory therapies for coronary artery disease. Nat Rev Drug Discov. 2002; 1: 122–130.[CrossRef][Medline] [Order article via Infotrieve]
15. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB J. 2003; 17: 1183–1185.[Abstract/Free Full Text]
16. Muzaffar S, Jeremy JY, Angelini GD, Stuart-Smith K, Shukla N. Role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries. Thorax. 2003; 58: 598–604.[Abstract/Free Full Text]
17. Wimalasundera R, Fexby S, Regan L, Thom SA, Hughes AD. Effect of tumor necrosis factor- and interleukin 1ß on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol. 2003; 138: 1285–1294.[CrossRef][Medline] [Order article via Infotrieve]
18. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002; 82: 47–95.[Abstract/Free Full Text]
19. Li JM, Shah AM. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem. 2002; 277: 19952–19960.[Abstract/Free Full Text]
20. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol. 2003; 285: R277–R297.
21. Fries DM, Paxinou E, Themistocleous M, Swanberg E, Griendling KK, Salvemini D, Slot JW, Heijnen HFG, Hazen, SL, Ischiropoulos H. Expression of inducible nitric oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells: role of reactive oxygen species. J Biol Chem. 2003; 278: 22901–22907.[Abstract/Free Full Text]
22. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003; 34: 2518–2532.[Abstract/Free Full Text]
23. Faraci FM, Sigmund CD, Shesely EG, Maeda N, Heistad DD. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Physiol. 1998; 274: H564–H570.[Medline] [Order article via Infotrieve]
24. Didion SP, Ryan MJ, Didion LA, Fegan PE, Sigmund CD, Faraci FM. Increased superoxide and vascular dysfunction in CuZn-SOD-deficient mice. Circ Res. 2002; 91: 938–944.[Abstract/Free Full Text]
25. Didion SP, Hathaway CA, Faraci FM. Superoxide levels and function of cerebral blood vessels after inhibition of CuZn-SOD. Am J Physiol. 2001; 281: H1697–H1703.
26. Yan T, Jiang X, Zhang HJ, Li S, Oberley LW. Use of commercial antibodies for detection of the primary antioxidant enzymes. Free Radical Biol Med. 1998; 25: 688–693.[CrossRef][Medline] [Order article via Infotrieve]
27. Kharbanda RK, Walton B, Allen M, Klein N, Hingorani AD, MacAllister RJ, Vallance P. Prevention of inflammation-induced endothelial dysfunction. A novel vasculo-protective action of aspirin. Circulation. 2002; 105: 2600–2604.[Abstract/Free Full Text]
28. Javesghani D, Hussain SN, Scheidel J, Quinn MT, Magder SA. Superoxide production in the vasculature of lipopolysaccharide-treated rats and pigs. Shock. 2003; 19: 486–493.[CrossRef][Medline] [Order article via Infotrieve]
29. Bachschmid M, Thurau S, Zou M-H, Ullrich V. Endothelial cell activation by endotoxin involves superoxide/NO-mediated nitration of prostacyclin synthase and thromboxane receptor stimulation. FASEB J. 2003; 17: 914–916.[Abstract/Free Full Text]
30. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cerebral Blood Flow Metabol. 2001; 21: 2–14.[CrossRef][Medline] [Order article via Infotrieve]
31. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest. 2000; 105: 1631–1639.[Medline] [Order article via Infotrieve]
32. Stralin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995: 15; 2032–2036.
33. Guo Z, Van Remmen H, Yang H, Chen X, Mele J, Vijg J, Epstein CJ, Ho Y-S, Richardson A. Changes in expression of antioxidant enzymes affect cell-mediated LDL oxidation and oxidized LDL-induced apoptosis in mouse aortic cells. Arterioscler Thromb Vasc Biol. 2001; 21: 1131–1138.[Abstract/Free Full Text]
34. Kamii H, Kato I, Kinouchi H, Chan PH, Epstein CJ, Akabane A, Okamoto H, Yoshimoto T. Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke. 1999; 30: 867–872.[Abstract/Free Full Text]
35. Didion SP. Faraci FM. Overexpression of CuZn-SOD protects against ceramide-induced endothelial dysfunction. FASEB J. 2002; 16: A1136. Abstract.
36. Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, Fischer E, Younkin S, Borchelt DR, Hsiao KK, Carlson GA. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci. 1999; 2: 157–161.[CrossRef][Medline] [Order article via Infotrieve]
37. Wang HD, Johns DG, Xu S, Cohen RA. Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II. Am J Physiol. 2002; 282: H1697–H1702.

This article has been cited by other articles:

				A. Kunz, L. Park, T. Abe, E. F. Gallo, J. Anrather, P. Zhou, and C. Iadecola Neurovascular Protection by Ischemic Tolerance: Role of Nitric Oxide and Reactive Oxygen Species J. Neurosci., July 4, 2007; 27(27): 7083 - 7093. [Abstract] [Full Text] [PDF]

				S. P. Didion, D. A. Kinzenbaw, L. I. Schrader, and F. M. Faraci Heterozygous CuZn Superoxide Dismutase Deficiency Produces a Vascular Phenotype With Aging Hypertension, December 1, 2006; 48(6): 1072 - 1079. [Abstract] [Full Text] [PDF]

				F. M. Faraci, M. L. Modrick, C. M. Lynch, L. A. Didion, P. E. Fegan, and S. P. Didion Selective cerebral vascular dysfunction in Mn-SOD-deficient mice J Appl Physiol, June 1, 2006; 100(6): 2089 - 2093. [Abstract] [Full Text] [PDF]

				S. P. Didion, D. A. Kinzenbaw, and F. M. Faraci Critical Role for CuZn-Superoxide Dismutase in Preventing Angiotensin II-Induced Endothelial Dysfunction Hypertension, November 1, 2005; 46(5): 1147 - 1153. [Abstract] [Full Text] [PDF]

				S. P. Didion and F. M. Faraci Ceramide-Induced Impairment of Endothelial Function Is Prevented by CuZn Superoxide Dismutase Overexpression Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 90 - 95. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 35/8/1963    most recent 01.STR.0000132764.06878.c5v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Didion, S. P. Articles by Faraci, F. M. Search for Related Content PubMed PubMed Citation Articles by Didion, S. P. Articles by Faraci, F. M. Related Collections Oxidant stress Endothelium/vascular type/nitric oxide Genetically altered mice